A growing need for capillaroscopy in rheumatology

Arthritis Care and Research

Volumn 61, Issue 3, 2009, Pages 405-410

  De Angelis, Rossella ^a   Grassi, Walter ^a   Cutolo, Maurizio ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ILOPROST; NIFEDIPINE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAPILLAROSCOPY; CAPILLARY FLOW; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FOLLOW UP; HEALTH SURVEY; HUMAN; MICROANGIOPATHY; PATIENT MONITORING; PREVALENCE; PROGNOSIS; RAYNAUD PHENOMENON; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK ASSESSMENT; SCLERODERMA; SIDE EFFECT; SYSTEMIC SCLEROSIS;

DIAGNOSIS, DIFFERENTIAL; FORECASTING; HUMANS; MICROSCOPIC ANGIOSCOPY; MICROSCOPY, VIDEO; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 62549122964     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24274     Document Type: Review

References (54)

1. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy. Arthritis Rheum 1973;16:619-28.
2. Lovy M, MacCarter D, Steigerwald JC. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 1985;28:496-501.
3. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. J Rheumatol 1986;13:556-63.
4. Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and followup of autoimmune rheumatic diseases: a future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford) 2006;45 Suppl 4:43-6.
5. Herrick AL, Hutchinson C. Vascular imaging. Best Pract Res Clin Rheumatol 2004;18:957-79.
6. Ingegnoli F, Boracchi P, Gualtierotti R, Lubatti C, Meani L, Zahalkova L, et al. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (Prognostic Index for Nailfold Capillaroscopic Examination). Arthritis Rheum 2008;58:2174 -82.
7. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
8. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, la Montagna G, et al. Systemic sclerosis: demographic, clinical, serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139-53.
9. Sindhu RJ, Feldman BM, Hawker GA. Classification criteria for systemic sclerosis subsets. J Rheumatol 2007;34:1855-63.
10. De Angelis R, Salaffi F, Grassi W. Raynaud's phenomenon: prevalence in an Italian population sample. Clin Rheum 2006; 25:506-10.
11. Block JA, Sequeira W. Raynaud's phenomenon. Lancet 2001;357:2042-8.
12. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003; 48:3023-30.
13. Beltran E, Toll A, Pros A, Carbonell J, Pujol RM. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud's phenomenon. Br J Dermatol 2007;156:892-8.
14. Ter Borg EJ, Piersma-Wichers G, Smit AJ, Kallemberg CG, Wouda AA. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma. Semin Arthritis Rheum 1994;24:40-7.
15. Cutolo M, Pizzorni C, Sulli A. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al [letter]. Arthritis Rheum 2007;56:2102-3.
16. Kim SH, Kim HO, Jeong YG, Lee SY, Yoo WH, Choi TH, et al. The diagnostic accuracy of power Doppler ultrasonography for differentiating secondary from primary Raynaud's phenomenon in undifferentiated connective tissue disease. Clin Rheumatol 2008;27:408-11.
17. Szabo N, Csiki Z, Szanto A, Danko K, Szodoray P, Zeher M. Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjögren's syndrome and poly / dermatomyositis. Scand J Rheumatol 2008;37:23-9.
18. Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance. Arthritis Rheum 2006;54:1974-81.
19. Grassi W, Del Medico P, Izzo F, Cervini C. Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 2001;30:397-402.
20. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold video-capillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
21. Kabasakal Y, Elvins DM, Ring EF, McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996;55:507-12.
22. Ohtsuka T, Tamura T, Yamakage A, Yamazaki S. The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 1998;139:622-9.
23. Anders HJ, Sigl T, Schattenkirchner N. Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 2001;60:407-9.
24. De Holanda Mafaldo Diogenes A, Bonfa E, Fuller R, Correia Caleiro MT. Capillaroscopy is a dynamic process in mixed connective tissue disease. Lupus 2007;16:254-8.
25. Monticone G, Colonna L, Palermi G, Bono R, Puddu P. Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis. J Am Acad Dermatol 2000;42:787-90.
26. Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008;67:885-7.
27. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983;1:195-205.
28. De Angelis R, Grassi W. Capillaroscopy: questions and answers. Clin Rheumatol 2007;26:2009-16.
29. Leteurtre E, Hachulla E, Janin A, Hatron PY, Brouillard M, Devulder B. Vascular manifestations of dermatomyositis and polymyositis: clinical, capillaroscopic and histological aspects. Rev Med Interne 1994;15:800-7.
30. Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM. Microvascular abnormalities in Sjögren's syndrome: nailfold capillaroscopy. Rheumatology (Oxford) 1999;38:826-30.
31. De Angelis R, Cerioni A, Del Medico P, Blasetti P. Raynaud's phenomenon in undifferentiated connective tissue disease. Clin Rheumatol 2005;24:145-51.
32. Rozboril MB, Maricq HR, Rodnan GP, Jablonska S, Bole GG. Capillary microscopy in eosinophilic fasciitis: a comparison with systemic sclerosis. Arthritis Rheum 1983;26:617-22.
33. Chen ZY, Silver RM, Ainsworth SK, Dobson RL, Rust P, Maricq HR. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984;77:812-22.
34. Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M, et al. Scleroderma patients nailfold videocapil-laroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 2007;46:1566-9.
35. Lee O, Leung FY, Alderdice C, Armstrong SK. Nailfold capillary microscopy in the connective tissue diseases: a semi-quantitative assessment. J Rheumatol 1983;10:930-8.
36. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 2004;43:719-26.
37. Grassi W, Core P, Carlino G, Cervini C. Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum 1994;37:384-90.
38. Filaci G, Cutolo M, Scudeletti M, Castagneto C, Derchi L, Gianrossi L, et al. Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology (Oxford) 1999;38:992-6.
39. Faggioli P, Giani L, Mazzone A. Possible role of iloprost (stable analogue of PGI2) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 2006;24:220-1.
40. Anderson ME, Allen PD, Moore T, Hillier V, Taylor CJ, Herrick AL. Computerized nailfold videocapillaroscopy: a new tool for assessment of Raynaud's phenomenon. J Rheumatol 2005;32:841-8.
41. Miniati I, Guiducci S, Conforti ML, Rogai V, Fiori G, Cinelli M, et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis 2009;68:94-8.
42. Groen H, ter Borg EJ, Postma DS, Wouda AA, van der Mark TW, Kallenberg CG. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am J Med 1992;93:619-27.
43. Furtado RN, Pucinelli ML, Cristo W, Andrade LE, Sato EI. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients. Lupus 2002;11:35-41.
44. Bongard O, Bounameaux H, Miescher PA, de Moerloose P. Association of anticardiolipin antibodies and abnormal nail- fold capillaroscopy in patients with systemic lupus erythematosus. Lupus 1995;4:142-4.
45. Sulli A, Pizzorni C, Cutolo M. Nailfold videocapillaroscopy in patients with antiphospholipid antibodies. J Rheumatol 2000;27:1574-6.
46. Zaric D, Worm AM, Stahl D, Clemmensen OJ. Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol 1981;10:249-52.
47. Grassi W, Core P, Carlino G, Cervini C. Nailfold capillary permeability in psoriatic arthritis. Scand J Rheumatol 1992; 21:226-30.
48. De Angelis R, Bugatti L, Del Medico P, Nicolini M, Filosa G. Videocapillaroscopic findings in the microcirculation of the psoriatic plaque. Dermatology 2002;204:236-9.
49. Rossi D, Mansouri M, Baldovino S, Gennaro M, Naretto C, Alpa M, et al. Nailfold videocapillaroscopy in mixed cryoglobulinaemia. Nephrol Dial Transplant 2004;19:2245-9.
50. Maricq HR, Valter I. A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 2004;22 Suppl 33:S5-13.
51. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma [letter]. Arthritis Rheum 2001;44:735-6.
52. Hudson M, Taillefer S, Steele R, Dunne J, Johnson SR, Jones N, et al. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007;25:754-7.
53. Cutolo M, Matucci Cerinic M. Nailfold capillaroscopy and classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007;25:663-5.
54. Cutolo M, Pizzorni C, Secchi ME, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol 2008;22:1093-108.